Sources sought
ProteinSimple Maurice consumables
75F40126SSN133285
Food and Drug Administration, FDA Office of Acq Grant SVCS. In-Vitro Diagnostic Substance Manufacturing.
Response deadline
July 24, 2026 at 3:00 PM EDT
Closed 100 days ago. Posted July 17, 2026. Scheduled to archive August 8, 2026.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2026
13 like it are open now in in-vitro diagnostic substance manufacturing
- NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes tomorrowNov 2 - VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ
Department of Veterans Affairs, 245-Network Contract Office 5
Combined synopsis and solicitationNAICS 325413Anywhere in the US36C24527Q0042Closes in 4 daysNov 5 - Blood Type IVD Reagents
Department of Veterans Affairs, 262-Network Contract Office 22
Combined synopsis and solicitationNAICS 325413Anywhere in the US36C26227Q0043Closes in 15 daysNov 16
Description
As published on SAM.gov.
See attached Sources Sought Notice for the FDA's requirement for consumables and materials for a capillary electrophoresis instrument (Protein Simple Maurice system [a Biotechne Brand], model: Maurice – OBM, serial number: KF-1804) (used to conduct regulatory research and testing supporting review of complex biopharmaceuticals).
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- SSN 75F40126SSN133285.pdf154 KB, July 17, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 17, 2026
Sources sought
Due July 24, 2026 at 3:00 PM EDT. SAM.gov, notice dfd818c7f4fc4799906626100e904371
2 revisions on SAM
- July 17, 2026: publish, sources sought
- August 1, 2026: publish, combined synopsis and solicitation
Points of contact
- Suzanne Martellasuzanne.martella@fda.hhs.gov3017962383